Rep. Julie Johnson Sells Procter & Gamble Company (The) (NYSE:PG) Shares

Representative Julie Johnson (D-Texas) recently sold shares of Procter & Gamble Company (The) (NYSE:PG). In a filing disclosed on January 15th, the Representative disclosed that they had sold between $1,001 and $15,000 in Procter & Gamble stock on December 18th. The trade occurred in the Representative’s “CHASE BROKERAGE ACCOUNT (3935)” account.

Representative Julie Johnson also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Texas Instruments (NASDAQ:TXN) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of General Dynamics (NYSE:GD) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of PepsiCo (NASDAQ:PEP) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of Dover (NYSE:DOV) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of Philip Morris International (NYSE:PM) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of Johnson & Johnson (NYSE:JNJ) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of Bank of America (NYSE:BAC) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of Walmart (NASDAQ:WMT) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of Republic Services (NYSE:RSG) on 12/18/2025.

Procter & Gamble Stock Down 0.1%

Procter & Gamble stock opened at $144.55 on Friday. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $179.99. The stock has a fifty day simple moving average of $144.72 and a two-hundred day simple moving average of $150.98. The company has a current ratio of 0.71, a quick ratio of 0.51 and a debt-to-equity ratio of 0.46. The firm has a market cap of $337.77 billion, a price-to-earnings ratio of 21.10, a PEG ratio of 4.88 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Friday, October 24th. The company reported $1.99 EPS for the quarter, beating the consensus estimate of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The company had revenue of $22.39 billion for the quarter, compared to analysts’ expectations of $22.23 billion. During the same period last year, the firm posted $1.93 earnings per share. Procter & Gamble’s revenue was up 3.0% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Equities analysts predict that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, February 17th. Shareholders of record on Friday, January 23rd will be paid a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.9%. The ex-dividend date is Friday, January 23rd. Procter & Gamble’s dividend payout ratio (DPR) is currently 61.75%.

Institutional Trading of Procter & Gamble

Institutional investors have recently made changes to their positions in the business. Halbert Hargrove Global Advisors LLC bought a new stake in shares of Procter & Gamble during the third quarter valued at approximately $25,000. Signature Resources Capital Management LLC lifted its stake in Procter & Gamble by 67.9% in the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after purchasing an additional 72 shares in the last quarter. Saranac Partners Ltd bought a new position in shares of Procter & Gamble during the 3rd quarter valued at about $30,000. Corundum Trust Company INC purchased a new position in shares of Procter & Gamble during the third quarter valued at about $32,000. Finally, Mid American Wealth Advisory Group Inc. bought a new stake in shares of Procter & Gamble in the second quarter worth about $34,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Wall Street Analysts Forecast Growth

PG has been the subject of a number of research analyst reports. Jefferies Financial Group upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and lifted their price target for the stock from $156.00 to $179.00 in a research note on Tuesday, December 16th. Morgan Stanley set a $175.00 target price on shares of Procter & Gamble in a research report on Monday, October 27th. Bank of America decreased their price target on shares of Procter & Gamble from $180.00 to $174.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Procter & Gamble from $176.00 to $171.00 and set a “buy” rating for the company in a research report on Monday, December 8th. Finally, Raymond James Financial decreased their target price on Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a report on Monday, October 20th. Fifteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $168.73.

Insider Buying and Selling

In other Procter & Gamble news, CAO Matthew W. Janzaruk sold 725 shares of the firm’s stock in a transaction that occurred on Thursday, October 30th. The stock was sold at an average price of $149.57, for a total transaction of $108,438.25. Following the completion of the transaction, the chief accounting officer owned 979 shares in the company, valued at $146,429.03. This trade represents a 42.55% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.20% of the company’s stock.

Procter & Gamble News Summary

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: P&G announced a dividend increase that pushed shares higher after the news; investors often view dividend raises as a sign of cash-flow confidence. Procter & Gamble (NYSE:PG) Shares Up 1.4% Following Dividend Announcement
• Positive Sentiment: UBS reiterated a Buy rating on PG, which can lend support to the stock by reinforcing institutional conviction. UBS Sticks to Their Buy Rating for Procter & Gamble (PG)
• Positive Sentiment: Dividend-focused coverage included P&G in a roundup of high-yield and dividend-resilient names, reinforcing interest from income-oriented investors. Dividend roundup: Goldman Sachs, Procter & Gamble, Costco, Caterpillar, and more
• Neutral Sentiment: Zacks published an in-depth preview of Q2 metrics (beyond EPS/revenue), offering models and expectations investors should watch when the quarter posts—useful for positioning but not an immediate catalyst. Insights Into P&G (PG) Q2: Wall Street Projections for Key Metrics
• Neutral Sentiment: The options market shows unusual activity that some interpret as signaling bigger moves ahead; this is mixed info—could indicate hedging or directional bets. Is the Options Market Predicting a Spike in Procter & Gamble Stock?
• Neutral Sentiment: P&G is scheduled to report earnings soon (projected posting), keeping the stock sensitive to the quarter’s top-line and margin details. Procter & Gamble (PG) Projected to Post Earnings on Thursday
• Neutral Sentiment: A comparative profile vs. smaller peer Synergy CHC was published; not directly market-moving for PG but helpful context for sector/peer analysis. Head to Head Comparison: Procter & Gamble (NYSE:PG) vs. Synergy CHC (NASDAQ:SNYR)
• Neutral Sentiment: P&G appears on lists of dividend-paying Dow stocks (Dogs of the Dow coverage), which can attract income-focused flows over time but is not an immediate catalyst. The Dogs of the Dow: 10 Downtrodden Dividends Paying Out Up to 6.8%
• Neutral Sentiment: Media noted that CEO stock incentives could meaningfully increase his compensation—this aligns management with shareholders but may raise questions about dilution/compensation structure for some investors. Procter & Gamble CEO could see major wealth boost from stock incentives
• Negative Sentiment: Zacks’ earnings preview warned Q2 EPS may decline and suggested P&G may lack the mix for an earnings beat—this raises short-term downside risk if results disappoint. Earnings Preview: Procter & Gamble (PG) Q2 Earnings Expected to Decline
• Negative Sentiment: Large put buying was reported (76,923 puts), a roughly 190% jump vs. typical volume—this is a bearish options signal that could amplify volatility or signal hedging against a near-term drop. Is the Options Market Predicting a Spike in Procter & Gamble Stock?
• Negative Sentiment: A report noted an insider (Rep. Gilbert Ray Cisneros, Jr.) sold shares; insider selling can be perceived negatively even if non-material. Procter & Gamble (NYSE:PG) Stock Unloaded Rep. Gilbert Ray Cisneros, Jr.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas’ 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

Johnson (Democratic Party) ran for election to the U.S. House to represent Texas’ 32nd Congressional District. She won in the general election on November 5, 2024.

Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson’s career experience includes working as an attorney.

Procter & Gamble Company Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.